ClinVar Miner

Submissions for variant NM_001035.3(RYR2):c.12648G>A (p.Ala4216=)

gnomAD frequency: 0.00002  dbSNP: rs781557399
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587919 SCV000697605 benign not provided 2017-01-09 criteria provided, single submitter clinical testing Variant summary: The RYR2 c.12648G>A (p.Ala4216Ala) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 6/120450 control chromosomes, exclusively observed in the East Asian subpopulation at a frequency of 0.0006975 (6/8602). This frequency is about 28 times the estimated maximal expected allele frequency of a pathogenic RYR2 variant (0.000025), suggesting this is likely a benign polymorphism found primarily in the populations of East Asian origin. The variant of interest has not, to our knowledge, been reported as germline mutation in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Ambry Genetics RCV000617652 SCV000737893 likely benign Cardiovascular phenotype 2017-01-31 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV002530911 SCV000760734 likely benign Catecholaminergic polymorphic ventricular tachycardia 1 2022-12-22 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001185316 SCV001351504 likely benign Cardiomyopathy 2019-12-09 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.